Melanotan II (MT-2) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that behaves as a non-selective agonist across the melanocortin receptor family. In published preclinical literature it is characterized as a structurally constrained ligand whose cyclization confers resistance to enzymatic degradation. This note summarizes its receptor pharmacology and the melanogenesis biochemistry studied in laboratory settings.

The melanocortin receptor family

The melanocortin system comprises five G-protein-coupled receptors, MC1R through MC5R, each coupled primarily to the stimulatory G-protein (Gs) and adenylyl cyclase. MT-2 is described in the literature as a broad, non-selective agonist that binds MC1R, MC3R, MC4R, and MC5R, in contrast to ligands engineered for single-subtype selectivity. This wide receptor engagement is the central feature distinguishing it from more selective melanocortin analogs in comparative binding studies.

The lactam-bridged cyclic structure

The defining structural element of MT-2 is an intramolecular lactam bridge formed between residues, producing a cyclic backbone rather than the open-chain configuration of native alpha-MSH. Published structure-activity work attributes the molecule's extended duration of activity and elevated binding affinity to this conformational constraint, which both pre-organizes the pharmacophore and reduces susceptibility to proteolytic cleavage. The cyclic scaffold is therefore central to its measured potency relative to the linear parent hormone.

MC1R signaling and melanogenesis

At MC1R, agonist binding activates adenylyl cyclase, raising intracellular cyclic AMP (cAMP) and activating protein kinase A. This cascade upregulates microphthalmia-associated transcription factor (MITF), which in turn drives transcription of tyrosinase and related enzymes that govern eumelanin formation within melanocytes. The pathway studied in cell-based models proceeds MC1R to cAMP to tyrosinase to eumelanin, making MC1R the principal node connecting melanocortin agonism to pigment biochemistry.

Analytical identity of a cyclic peptide

Confirming the identity of a cyclic peptide such as MT-2 requires methods sensitive to its constrained topology. Reversed-phase HPLC resolves the cyclic species from linear precursors and process-related impurities, while LC-MS provides accurate-mass confirmation of the intact ring and any characteristic fragmentation. Because the lactam bridge alters both chromatographic retention and fragmentation behavior, orthogonal analytical methods are used together to verify the cyclic structure against an analytical reference.

Comparative pharmacology in the literature

Comparative studies position MT-2 as a high-affinity, long-acting, broadly non-selective melanocortin agonist, frequently used as a reference ligand when characterizing receptor subtype behavior in vitro. Its non-selectivity makes it informative for mapping the shared signaling architecture of the melanocortin receptors, even as more selective analogs are developed to isolate individual subtype contributions in research contexts.

These materials are for laboratory research use only and are not for human or veterinary use.